Mednet Logo
HomePrimary CareQuestion

How do you approach management of new onset ILD in a patient with RA who is otherwise well controlled on methotrexate or leflunomide?

4
2 Answers
Mednet Member
Mednet Member
Rheumatology · University of Washington

We do not have any randomized controlled trials for DMARDs in RA-ILD. Most of the data is case series or retrospective analysis. Nonetheless, we can use current data to at least make clinical decisions until we receive more direction from high-quality clinical trials. We now know that in general met...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Pulmonology · Thomas Jefferson University Hospitals

First and foremost. Is the ILD truly connected to the RA or therapy? I prefer to perform bronchoscopy with BAL stains and cultures, as well as cell differential, if it can be done safely. I want reassurance that this immunocompromised individual does not have an opportunistic infection causing diffu...

Register or Sign In to see full answer

How do you approach management of new onset ILD in a patient with RA who is otherwise well controlled on methotrexate or leflunomide? | Mednet